Pharmacokinetics and disposition of clenbuterol in the horse

Journal of Veterinary Pharmacology and Therapeutics

Volumn 27, Issue 2, 2004, Pages 71-77

  Soma, L R ^a   Uboh, C E ^a,b   Guan, F ^a   Moate, P ^a   Luo, Y ^a   Teleis, D ^a   Li, R ^b   Birks, E K ^a   Rudy, J A ^a   Tsang, D S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WEST CHESTER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLENBUTEROL;

ARTICLE; BLOOD LEVEL; BREEDING; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISPOSITION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HORSE; KIDNEY CONCENTRATING CAPACITY; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BRONCHODILATOR AGENTS; CLENBUTEROL; FEMALE; HALF-LIFE; HORSES; INJECTIONS, INTRAVENOUS; INTESTINAL ABSORPTION; METABOLIC CLEARANCE RATE; TISSUE DISTRIBUTION;

EQUIDAE; EQUUS CABALLUS;

EID: 2442445245     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2004.00553.x     Document Type: Article

References (38)

1. Akaike, H. (1973) A new look at statistical model identification. Transactions Automatic Control, 19, 716-723.
2. Akaike, H. (1976) An information criterion (AIC). Mathamatical Science, 14, 5-9.
3. Baggot, J.D. (1977) Principles of Drug Disposition in Domestic Animals: Basis of Veterinary Clinical Pharmacology. pp. 204. W.B. Saunders, Philadelphia, PA.
4. Boner, A.L., Bennatt, D., Castellani, C., Sette, L. & Schiassi, M. (1987a) Bronchodilating activity of oral clenbuterol in asthmatic children after single administration of different dosages. Pediatric Pulmonology, 3, 34-37.
5. Boner, A.L., Sette, L., Castellani, C. & Schiassi, M. (1987b) Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma. Journal of Asthma, 24, 347-353.
6. Boston, R.C., Greif, P.C. & Bermn, M. (1981) Conversational SAAM: an interactive program for kinetic analysis of biological systems. Computer Programming Biomedical, 13, 111-119.
7. Collett, L., Kamerling, S., Woods, W.E., Weckman, T., Nugent, T., DeQuick, D. & Tobin, T. (1983) Clearance times and behavioral effects of clenbuterol in the horse. Proceedings of the 5th International Conference of Cont. Use Drugs Racehorses, Toronto, Canada.
8. Dixon, P.M. (1992) Respiratory mucociliary clearance in the horse in health and disease, and its pharmaceutical modification. Veterinary Record, 131, 229-235.
9. Dumasia, M.C. & Houghton, E. (1991) Screening and confirmatory analysis of beta-agonists, beta-antagonists and their metabolites in horse urine by capillary gas chromatography-mass spectrometry. Journal of Chromatography A, 564, 503-513.
10. Erichsen, D.F., Aviad, A.D., Schultz, R.H. & Kennedy, T.J. (1994) Clinical efficacy and safety of clenbuterol HCl when administered to effect in horses with chronic obstructive pulmonary disease (COPD) [see comments]. Equine Veterinary Journal, 26, 331-336.
11. Gabrielsson, J. & Weiner, D. (2000) Pharmacokinetic and pharmacodynamic data analysis: Concepts & Application. Swedish Pharmaceutical Press, Stockholm, 314-315.
12. Guan, F., Uboh, C.E., Soma, L.R., Luo, Y., Li, R., Birks, E.K., Teleis, D., Rudy, J.A. & Tsang, D.S. (2002) Quantification of clenbuterol in equine plasma, urine and tissue by liquid chromatography coupled on-line with quadrupole time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry, 16, 1642-1651.
13. Hagedorn, H.W., Zuck, S. & Schulz, R. (1995) Detection of clenbuterol (Ventipulmin) in the horse. Zentralblatt fur Veterinarmedizin - Reihe A, 42, 209-219.
14. Harkins, J.D., Robinson, N.B., Woods, W.E., Lehner, A.F., Smith, M.D., Gates, R.S., Fisher, M. & Tobin, T. (2000) Intratracheal clenbuterol in the horse: its pharmacological efficacy and analytical detection. Journal of Veterinary Pharmacology and Therapeutics, 23, 251-260.
15. Johnston A.M. & Dunsire J.P (1996) Plasma kinetics, metabolism, excretion and residue kinetics of [14C]-N-AB 365 Cl following oral administration to the horse. Submitted to World Health Organization by Boehringer Ingelheim Vetmedica GmbH, Ingelheim am Rhein, Germany. Cited: Woodward, K.N. Toxicological evaluation of certain veterinary drug residues in food. WHO Food Additives Series, 38, 35-43.
16. Kallings, P., Ingvast-Larsson, C., Persson, S., Appelgren, L.E., Forster, H.J. & Rominger, K.L. (1991) Clenbuterol plasma concentrations after repeated oral administration and its effects on cardio-respiratory and blood lactate responses to exercise in healthy Standardbred horses. Journal of Veterinary Pharmacology & Therapeutics, 14, 243-249.
17. Kleemann, R., Goossens, L., Reder, E. & Quirke, J.F. (1999) Depletion kinetics of clenbuterol hydrochloride in competition horses. Equine Veterinary Journal, 31, 339-341.
18. Kopitar, Z. & Zimmer, A. (1976a) [Comparison of the pharmacokinetic profiles of clenbuterol in rat and dog during toxicological studies (author's transl)]. Arzneimittel-Forschung, 26, 1450-1455.
19. Kopitar, Z. & Zimmer, A. (1976b) [Pharmacokinetics and metabolite pattern of clenbuterol in the rat]. Arzneimittel-Forschung, 26, 1435-1441.
20. Lehner, A.F., Harkins, J.D., Karpiesiuk, W., Woods, W.E., Robinson, N.B., Dirikolu, L., Fisher, M. & Tobin, T. (2001) Clenbuterol in the horse: confirmation and quantitation of serum clenbuterol by LC-MS-MS after oral and intratracheal administration. Journal of Analytical Toxicology, 25, 280-287.
21. Mair, T.S. (1996) Obstructive pulmonary disease in 18 horses at summer pasture. Veterinary Record, 138, 89-91.
22. Morgan, D.J. (1990) Clinical pharmacokinetics of beta-agonists. Clinical Pharmacokinetics, 18, 270-294.
23. Petkova, M. & Stanchev, H. (1996) Study on the effect of clenbuterol on fattening calves. Zhivotnov'Dni Nauki, 33, 44-48.
24. Popa, V. (1986) Respiratory pharmacology. Beta-adrenergic drugs. Clinics in Chest Medicine, 7, 313-329.
25. Powers, J. (1990) Statistical analysis of pharmacokinetic data. Journal of Veterinary Pharmacology & Therapeutics, 13, 113-120.
26. Sauer, M.J., Pickett, R.J., Limer, S. & Dixon, S.N. (1995) Distribution and elimination of clenbuterol in tissues and fluids of calves following prolonged oral administration at a growth-promoting dose. Journal of Veterinary Pharmacology & Therapeutics, 18, 81-86.
27. Shapland, J.E., Garner, H.E. & Hatfield, D.G. (1981) Cardiopulmonary effects of clenbuterol in the horse. Journal of Veterinary Pharmacology & Therapeutics, 4, 43-50.
28. Smith, D.J. & Paulson, G.D. (1997) Distribution, elimination, and residues of [14C]clenbuterol HCl in Holstein calves. Journal of Animal Science, 75, 454-461.
29. Stefanovski, D., Moate, P.J. & Boston, C. (2003) WinSAAM: a windows based compartmental modeling system. Journal of Metabolism, 52, 1153-1166.
30. Toutain, P.L. & Lassourd, V. (2002) Pharmacokinetic/pharmacodynamic approach to assess irrelevant plasma or urine drug concentrations in postcompetition samples for drug control in the horse [comment]. Equine Veterinary Journal, 34, 242-249.
31. Wastney, M.E., Patterson, B.H., Linares, O.A., Greif, P.C. & Boston, R.C. (1999) Investigating Biological Systems Using Modeling: Strategies and Software. Acadmedic Press, New York.
32. Weast, R.C. (1973) Handbook of Chemistry and Physics. CRC Press, Cleveland, OH, D-126.
33. Yamamoto, I., Iwata, K. & Nakashima, M. (1985) Pharmacokinetics of plasma and urine clenbuterol in man, rat, and rabbit. Journal of Pharmacobio-Dynamics, 8, 385-391.
34. Zalko, D., Bories, G. & Tulliez, J. (1998a) Metabolic fate of clenbuterol in calves. Journal of Agricultural Food and Chemistry, 46, 1935-1943.
35. Zalko, D., Debrauwer, L., Bories, G. & Tulliez, J. (1998b) Metabolism of clenbuterol in rats. Drug Metabolism & Disposition, 26, 891-899.
36. Zalko, D., Perdu-Durand, E., Debrauwer, L., Bec-Ferte, M.P. & Tulliez, J. (1998c) Comparative metabolism of clenbuterol by rat and bovine liver microsomes and slices. Drug Metabolism & Disposition, 26, 28-35.
37. Zimmer, A. (1976a) [Pharmacokinetics and metabolite pattern of clenbuterol in rabbit and dog (author's transl)]. Arzneimittel-Forschung, 26, 1442-1445.
38. Zimmer, A. (1976b) [Single and multiple applications and metabolite pattern of clenbuterol in man (author's transl)]. Arzneimittel-Forschung, 26, 1446-1450.